Granite Group Advisors’s Gilead Sciences GILD Stock Holding History

Granite Group Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23,554	Closed	-$2.18M	–	80
2024 Q4	$2.18M	Sell	23,554 -1,935	-8%	-$174K	1.39%	20
2024 Q3	$2.14M	Sell	25,489 -336	-1%	-$25.6K	1.37%	21
2024 Q2	$1.77M	Sell	25,825 -356	-1%	-$23.8K	1.34%	22
2024 Q1	$1.92M	Sell	26,181 -134	-0.5%	-$10.3K	1.29%	18
2023 Q4	$1.98M	Buy	+26,315	New	+$2.05M	1.4%	17

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Granite Group Advisors's GILD Position: Q1 2025 in Review

Granite Group Advisors sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 23,554 shares — an estimated $2.18M sold.

Granite Group Advisors first reported a position in GILD in Q4 2023 and held it in 5 quarters. The position peaked at $2.18M in Q4 2024. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Granite Group Advisors reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Granite Group Advisors sold 23,554 Gilead Sciences shares in Q1 2025, an estimated $2.18M.
Granite Group Advisors first reported a position in Gilead Sciences in Q4 2023 and held it in 5 quarters.
Granite Group Advisors's Gilead Sciences position peaked at $2.18M in Q4 2024.
2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Granite Group Advisors's 13F filing for Q1 2025, filed 6 May 2025.